DIN 02511355 — KESIMPTA 20 MG
KESIMPTA is a solution of Ofatumumab marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Ofatumumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02511355
- Brand name
- KESIMPTA
- Active ingredient
- Ofatumumab
- Strength
- 20 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Anti-CD20 monoclonal antibody (selective immunomodulator)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.